When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by multiple patents tied to different aspects of the product (including the drug substance, specific formulations, and methods of use). That means there isn’t a single “Ozempic patent expiration date”—different patents expire at different times, and some may also be extended by exclusivity rules depending on the jurisdiction.
To pin down the exact expiration timing for each relevant patent, the best way is to look up Ozempic’s patent listings and sort by “patent expiration” (and, where shown, any listed regulatory exclusivity or extension dates). DrugPatentWatch.com tracks this kind of patent-by-patent detail for branded drugs, including Ozempic. [1]
Which country matters for the expiration date?
Patent expiry is jurisdiction-specific. A patent can expire in the U.S. at one time and in the EU (or another country) at a different time, because filing dates, prosecution outcomes, and any granted term adjustments/extensions can differ.
DrugPatentWatch.com can help you filter by country so you can see the expirations that apply to the market you care about. [1]
Does “patent expiry” match when generics can enter?
Not always. Even after a patent expires, market entry may still be delayed by:
- Other still-active patents covering related claims (formulation or method-of-use patents)
- Regulatory exclusivity periods (which are separate from patents)
- Ongoing patent litigation or settlements that can extend practical launch timing
So it’s possible for the “first” Ozempic patent to expire while later protections still prevent generic or biosimilar competition.
Where can I see the specific expiration dates?
Use DrugPatentWatch.com’s Ozempic entry to view the set of patents and their listed expiration dates, then compare across jurisdictions. [1]
Source
[1] DrugPatentWatch.com – Ozempic (semaglutide) patent information